You May Also Like

COVID-19 vaccine : quick reference guide for healthcare professionals
Cite
CITE Title : COVID-19 vaccine : quick reference guide for healthcare professionals Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.) Published Date : 11/24/2021 URL : https://stacks.cdc.gov/view/cdc/111996 Centers for Disease Control and Prevention (U.S.) (2021). COVID-19 vaccine : quick reference guide for healthcare professionals. Centers for Disease Control and Prevention (U.S.) "COVID-19 vaccine : quick reference guide for healthcare professionals" (2021) Centers for Disease Control and Prevention (U.S.) "COVID-19 vaccine : quick reference guide for healthcare professionals" , 2021 Export RIS Citation Information.
Copy Copied Save
Generic APA MLA Chicago RIS
[PDF - 158.07 KB]
Corporate Authors:
Centers for Disease Control and Prevention (U.S.)
11/24/2021
Description:
The table below provides basic information on the proper storage, preparation, and administration of the currently authorized COVID-19 vaccine product...
File Type:
[PDF - 158.07 KB]
File Type:
[PDF - 158.07 KB]

Summary document for interim clinical considerations for use of COVID-19 vaccines currently authorized in the United States
Cite
CITE Title : Summary document for interim clinical considerations for use of COVID-19 vaccines currently authorized in the United States Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.) Published Date : 12/06/2022 URL : https://stacks.cdc.gov/view/cdc/123540 Centers for Disease Control and Prevention (U.S.) (2022). Summary document for interim clinical considerations for use of COVID-19 vaccines currently authorized in the United States. Centers for Disease Control and Prevention (U.S.) "Summary document for interim clinical considerations for use of COVID-19 vaccines currently authorized in the United States" (2022) Centers for Disease Control and Prevention (U.S.) "Summary document for interim clinical considerations for use of COVID-19 vaccines currently authorized in the United States" , 2022 Export RIS Citation Information.
Copy Copied Save
Generic APA MLA Chicago RIS
[PDF - 178.80 KB]
Corporate Authors:
Centers for Disease Control and Prevention (U.S.)
12/06/2022
Description:
COVID-19 vaccine products currently approved or authorized in the United States12/06/2022 CS321571-Wsummary-interim-clinical-considerations.pdf
File Type:
[PDF - 178.80 KB]
File Type:
[PDF - 178.80 KB]